Issued Patents 2025
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12427144 | Compounds and methods for the targeted degradation of androgen receptor | Lawrence B. Snyder, Andrew P. Crew, Hanqing Dong | 2025-09-30 |
| 12403142 | Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety | Troy David Patterson, Ze Tian | 2025-09-02 |
| 12310975 | Modulators of BCL6 proteolysis and associated methods of use | Michael Berlin, Hanqing Dong, Dan Sherman, Lawrence B. Snyder, Wei Zhang | 2025-05-27 |
| 12275716 | Modulators of estrogen receptor proteolysis and associated methods of use | Andrew P. Crew, Hanqing Dong, Keith R. Hornberger, Yimin Qian, Craig M. Crews | 2025-04-15 |
| 12264157 | Compounds and methods for the enhanced degradation of targeted proteins | Andrew P. Crew, Craig M. Crews, Xin Chen, Hanqing Dong, Caterina Ferraro +6 more | 2025-04-01 |
| 12239711 | Cereblon ligands and bifunctional compounds comprising the same | Andrew P. Crew, Craig M. Crews, Hanqing Dong, Keith R. Hornberger, Yimin Qian +1 more | 2025-03-04 |
| 12209074 | SHP2 phosphatase allosteric inhibitor | Huting Wang, Lei Zhang, Yonggang Wang, Lixin Fan, Lei Liu +6 more | 2025-01-28 |
| 12208095 | Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders | Andrew P. Crew, John Flanagan, Sheryl Maxine GOUGH, Royal J. HASKELL, III, Marcia Dougan MOORE +2 more | 2025-01-28 |